Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

Early response to chemotherapy has a major prognostic impact in acute myeloid leukemia patients treated with a double induction strategy. Less is known about patients treated with standard-dose cytarabine and anthracycline. We designed a risk-adapted remission induction regimen in which a second cou...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bertoli, Sarah, Bories, Pierre, Béné, Marie C., Daliphard, Sylvie, Lioure, Bruno, Pigneux, Arnaud, Vey, Norbert, Delaunay, Jacques, Leymarie, Vincent, Luquet, Isabelle, Blanchet, Odile, Cornillet-Lefebvre, Pascale, Hunault, Mathilde, Bouscary, Didier, Fegueux, Nathalie, Guardiola, Philippe, Dreyfus, François, Harousseau, Jean Luc, Cahn, Jean Yves, Ifrah, Norbert, Récher, Christian
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2014
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007924/
https://ncbi.nlm.nih.gov/pubmed/23975179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.091819
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items